Article Detail - JE Part B

The following new and deleted National Level II modifiers and HCPCS are effective for dates of service on and after January 1, 2013.

New Modifiers

Modifier and Description

• CH-0 PERCENT IMPAIRED, LIMITED OR RESTRICTED
• CI-AT LEAST 1 PERCENT BUT LESS THAN 20 PERCENT IMPAIRED, LIMITED OR RESTRICTED
• CJ-AT LEAST 20 PERCENT BUT LESS THAN 40 PERCENT IMPAIRED, LIMITED OR RESTRICTED
• CK-AT LEAST 40 PERCENT BUT LESS THAN 60 PERCENT IMPAIRED, LIMITED OR RESTRICTED
• CL-AT LEAST 60 PERCENT BUT LESS THAN 80 PERCENT IMPAIRED, LIMITED OR RESTRICTED
• CM-AT LEAST 80 PERCENT BUT LESS THAN 100 PERCENT IMPAIRED, LIMITED OR RESTRICTED
• CN-100 PERCENT IMPAIRED, LIMITED OR RESTRICTED
• LM-LEFT MAIN CORONARY ARTERY
• RI-RAMUS INTERMEDIUS CORONARY ARTERY

New 2013 HCPCS

HCPCS and Description

• A4435-Ostomy pouch, drainable, high output, with extended wear barrier (one-piece system), with or without filter, each
• A9586-Florbetapir f18, diagnostic, per study dose, up to 10 millicuries
• D0190-Screening of a patient
• D0191-Assessment of a patient
• D0364-Cone beam ct capture and interpretation with limited field of view - less than one whole jaw
• D0365-Cone beam ct capture and interpretation with field of view of one full dental arch - mandible
• D0366-Cone beam ct capture and interpretation with field of view of one full dental arch - maxilla, with or without cranium
• D0367-Cone beam ct capture and interpretation with field of view of both jaws, with or without cranium
• D0368-Cone beam ct capture and interpretation for tmj series including two or more exposures
• D0369-Maxillofacial mri capture and interpretation
• D0370-Maxillofacial ultrasound capture and interpretation
• D0371-Sialoendoscopy capture and interpretation
• D0380-Cone beam ct image capture with limited field of view - less than one whole jaw
• D0381-Cone beam ct image capture with field of view of one full dental arch - mandible
• D0382-Cone beam ct image capture with field of view of one full dental arch - maxilla, with or without cranium
• D0383-Cone beam ct image capture with field of view of both jaws, with or without cranium
• D0384-Cone beam ct image capture for tmj series including two or more exposures
• D0385-Maxillofacial mri image capture
• D0386-Maxillofacial ultrasound image capture
• D0391-Interpretation of diagnostic image by a practitioner not associated with capture of the image, including report
• D1208-Topical application of fluoride
• D2929-Prefabricated porcelain/ceramic crown - primary tooth
• D2981-Inlay repair necessitated by restorative material failure
• D2982-Onlay repair necessitated by restorative material failure
• D2983-Veneer repair necessitated by restorative material failure
• D2990-Resin infiltration of incipient smooth surface lesions
• D4212-Gingivectomy or gingivoplasty to allow access for restorative procedure, per tooth
• D4277-Free soft tissue graft procedure (including donor site surgery), first tooth or edentulous tooth position in graft
• D4278-Free soft tissue graft procedure (including donor site surgery), each additional contiguous tooth or edentulous tooth position in same graft site
• D6051-Interim abutment
• D6101-Debridement of a periimplant defect and surface cleaning of exposed implant surfaces, including flap entry and closure
• D6102-Debridement and osseous contouring of a periimplant defect; includes surface cleaning of exposed implant surfaces and flap entry and closure
• D6103-Bone graft for repair of periimplant defect - not including flap entry and closure or, when indicated, placement of a barrier membrane or biologic materials to aid in osseous regeneration
• D6104-Bone graft at time of implant placement
• D7921-Collection and application of autologous blood concentrate product
• D7952-Sinus augmentation via a vertical approach
• D9975-External bleaching for home application, per arch; includes materials and fabrication of custom trays
• G0452-Molecular pathology procedure; physician interpretation and report
• G0453-Continuous intraoperative neurophysiology monitoring, from outside the operating room (remote or nearby), per patient, (attention directed exclusively to one patient) each 15 minutes (list in addition to primary procedure)
• G0454-Physician documentation of face-to-face visit for durable medical equipment determination performed by nurse, physician assistant or clinical nurse specialist
• G0455-Preparation with instillation of fecal microbiota by any method, including assessment of donor specimen
• G0456-Negative pressure wound therapy, (e. G. Vacuum assisted drainage collection) using a mechanically-powered device, not durable medical equipment, including provision of cartridge and dressing(s), topical application(s), wound assessment, and instructions for ongoing care, per session; total wounds(s) surface area less than or equal to 50 square centimeters
• G0457-Negative pressure wound therapy, (e. G. Vacuum assisted drainage collection) using a mechanically-powered device, not durable medical equipment, including provision of cartridge and dressing(s), topical application(s), wound assessment, and instructions for ongoing care, per session; total wounds(s) surface area greater than 50 square centimeters
• G0458-Low dose rate (ldr) prostate brachytherapy services, composite rate
• G8907-Patient documented not to have experienced any of the following events: a burn prior to discharge; a fall within the facility; wrong site/side/patient/procedure/implant event; or a hospital transfer or hospital admission upon discharge from the facility
• G8908-Patient documented to have received a burn prior to discharge
• G8909-Patient documented not to have received a burn prior to discharge
• G8910-Patient documented to have experienced a fall within asc
• G8911-Patient documented not to have experienced a fall within ambulatory surgical center
• G8912-Patient documented to have experienced a wrong site, wrong side, wrong patient, wrong procedure or wrong implant event
• G8913-Patient documented not to have experienced a wrong site, wrong side, wrong patient, wrong procedure or wrong implant event
• G8914-Patient documented to have experienced a hospital transfer or hospital admission upon discharge from asc
• G8915-Patient documented not to have experienced a hospital transfer or hospital admission upon discharge from asc
• G8916-Patient with preoperative order for iv antibiotic surgical site infection (ssi) prophylaxis, antibiotic initiated on time
• G8917-Patient with preoperative order for iv antibiotic surgical site infection (ssi) prophylaxis, antibiotic not initiated on time
• G8918-Patient without preoperative order for iv antibiotic surgical site infection (ssi) prophylaxis
• G8919-Most recent systolic blood pressure < 140 mmhg
• G8920-Most recent systolic blood pressure >= 140 mmhg
• G8921-Most recent diastolic blood pressure < 90 mmhg
• G8922-Most recent diastolic blood pressure >= 90 mmhg
• G8923-Left ventricular ejection fraction (lvef) < 40% or documentation of moderately or severely depressed left ventricular systolic function
• G8924-Spirometry test results demonstrate fev1/fvc <60% with copd symptoms (e. G. ,dyspnea, cough/sputum, wheezing)
• G8925-Spirometry test results demonstrate fev1/fvc >=60% or patient does not have copd symptoms
• G8926-Spirometry test not performed or documented, reason not given
• G8927-Adjuvant chemotherapy referred, prescribed or previously received for ajcc stage iii, colon cancer
• G8928-Adjuvant chemotherapy not prescribed or previously received, reason given
• G8929-Adjuvant chemotherapy not prescribed or previously received, reason not given
• G8930-Assessment of depression severity not documented, reason not given
• G8931-Assessment of depression severity not documented, reason not given
• G8932-Suicide risk assessed at the initial evaluation
• G8933-Suicide risk not assessed at the initial evaluation, reason not given
• G8934-Left ventricular ejection fraction (lvef) <40% or documentation of moderately or severely depressed left ventricular systolic function
• G8935-Clinician prescribed angiotensin converting enzyme (ace) inhibitor or angiotensin receptor blocker (arb) therapy
• G8936-Clinician documented that patient was not an eligible candidate for angiotensin converting enzyme (ace) inhibitor or angiotensin receptor blocker (arb) therapy
• G8937-Clinician did not prescribe angiotensin converting enzyme (ace) inhibitor or angiotensin receptor blocker (arb) therapy, reason not given
• G8938-Bmi is calculated, but patient not eligible for follow-up plan
• G8939-Pain assessment documented, follow-up plan not documented, patient not eligible/appropriate
• G8940-Screening for clinical depression documented, follow-up plan not documented, patient not eligible/appropriate
• G8941-Elder maltreatment screen documented, patient not eligible for follow-up
• G8942-Documented functional outcomes assessment and care plan within the previous 30 days
• G8943-Ldl-c result not present or not within 12 months prior
• G8944-Ajcc melanoma cancer stage 0 through iic melanoma
• G8945-Aneurysm minor diameter <= 6 cm for men
• G8946-Minimally invasive biopsy method attempted but not diagnostic of breast cancer (e. G. , high risk lesion of breast such as atypical ductal hyperplasia, lobular neoplasia, atypical lobular carcinoma in situ, atypical columnar hyperplasica, flat epithelial atypia, radial scar, complex sclerosing lesion, papillary lesion, or any lesion with spindle cells)
• G8947-One or more neuropsychiatric symptoms
• G8948-No neuropsychiatric symptoms
• G8949-Documentation of patient reason(s) for patient not receiving counseling for diet and physical activity (e. G. , patient is not willing to discuss diet or exercise interventions to help control blood pressure, or the patient said he/she refused to make these changes)
• G8950-Pre-hypertensive or hypertensive blood pressure reading documented, indicated follow-up documented
• G8951-Pre-hypertensive or hypertensive blood pressure reading documented, indicated follow-up not documented, patient not eligible/not appropriate
• G8952-Pre-hypertensive or hypertensive blood pressure reading documented, indicated follow-up not documented, reason not given
• G8953-All quality actions for the applicable measures in the oncology measures group have been performed for this patient
• G8954-Complete and appropriate patient data were reported to a qualified clinical database registry
• G8955-Most recent assessment of adequacy of volume management
• G8956-Patient receiving maintenance hemodialysis in an outpatient dialysis facility
• G8957-Patient not receiving maintenance hemodialysis in an outpatient dialysis facility
• G8958-Assessment of adequacy of volume management not documented, reason not given
• G8959-Clinician treating major depressive disorder communicates to clinician treating comorbid condition
• G8960-Clinician treating major depressive disorder did not communicate to clinician treating comorbid condition, reason not given
• G8961-Cardiac stress imaging test primarily performed on low-risk surgery patient for preoperative evaluation within 30 days preceding this surgery
• G8962-Cardiac stress imaging test performed on patient for any reason including those who did not have low risk surgery or test that was performed more than 30 days preceding low risk surgery
• G8963-Cardiac stress imaging performed primarily for monitoring of asymptomatic patient who had pci within 2 years
• G8964-Cardiac stress imaging test performed primarily for any other reason than monitoring of asymptomatic patient who had pci within 2 years (e.G. , symptomatic patient, patient greater than 2 years since pci, initial evaluation, etc)
• G8965-Cardiac stress imaging test primarily performed on low chd risk patient for initial detection and risk assessment
• G8966-Cardiac stress imaging test performed on symptomatic or higher than low chd risk patient or for any reason other than initial detection and risk assessment
• G8967-Warfarin or another oral anticoagulant that is fda approved prescribed
• G8968-Documentation of medical reason(s) for not prescribing warfarin or another oral anticoagulant that is fda approved not prescribed (e. G. , allergy, risk of bleeding, transient or reversible causes of atrial fibrillation, other medical reasons including, but not limited to pregnancy, mitral stenosis, prosthetic heart valve or patient is in the postoperative period)
• G8969-Documentation of patient reason(s) for not prescribing warfarin or another oral anticoagulant that is fda approved (e. G. , economic, social, and/or religious impediments, noncompliance or patient refusal, other patient reasons)
• G8970-No risk factors or one moderate risk factor for thromboembolism
• G8971-Warfarin or another oral anticoagulant that is fda approved not prescribed, reason not given
• G8972-One or more high risk factors for thromboembolism or more than one moderate risk factor for thromboembolism
• G8973-Most recent hemoglobin (hgb) level < 10 g/dl
• G8974-Hemoglobin level measurement not documented, reason not given
• G8975-Documentation of medical reason(s) for patient having a hemoglobin level < 10 g/dl (e. G. , patients who have non-renal etiologies of anemia [e. G. , sickle cell anemia or other hemoglobinopathies, hypersplenism, primary bone marrow disease, anemia related to chemotherapy for diagnosis of malignancy, postoperative bleeding, active bloodstream or peritoneal infection], other medical reasons)
• G8976-Most recent hemoglobin (hgb) level >= 10 g/dl
• G8977-I intend to report the oncology measures group
• G8978-Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals
• G8979-Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting
• G8980-Mobility: walking & moving around functional limitation, discharge status, at discharge from therapy or to end reporting
• G8981-Changing & maintaining body position functional limitation, current status, at therapy episode outset and at reporting intervals
• G8982-Changing & maintaining body position functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting
• G8983-Changing & maintaining body position functional limitation, discharge status, at discharge from therapy or to end reporting
• G8984-Carrying, moving & handling objects functional limitation, current status, at therapy episode outset and at reporting intervals
• G8985-Carrying, moving & handling objects functional limitation, current status, at therapy episode outset and at reporting intervals
• G8986-Carrying, moving & handling objects functional limitation, discharge status, at discharge from therapy or to end reporting
• G8987-Self care functional limitation, current status, at therapy episode outset and at reporting intervals
• G8988-Self care functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting
• G8989-Self care functional limitation, discharge status, at discharge from therapy or to end reporting
• G8990-Other physical or occupational primary functional limitation, current status, at therapy episode outset and at reporting intervals
• G8991-Other physical or occupational primary functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting
• G8992-Other physical or occupational primary functional limitation, discharge status, at discharge from therapy or to end reporting
• G8993-Other physical or occupational subsequent functional limitation, current status, at therapy episode outset and at reporting intervals
• G8994-Other physical or occupational subsequent functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting
• G8995-Other physical or occupational subsequent functional limitation, discharge status, at discharge from therapy or to end reporting
• G8996-Swallowing functional limitation, current status at time of initial therapy treatment/episode outset and reporting intervals
• G8997-Swallowing functional limitation, projected goal status, at initial therapy treatment/outset and at discharge from therapy
• G8998-Swallowing functional limitation, discharge status, at discharge from therapy/end of reporting on limitation
• G8999-Motor speech functional limitation, current status at time of initial therapy treatment/episode outset and reporting intervals
• G9148-National committee for quality assurance - level i medical home
• G9149-National committee for quality assurance - level 2 medical home
• G9150-National committee for quality assurance - level 3 medical home
• G9151-Mapcp demonstration - state provided services
• G9152-Mapcp demonstration - community health teams
• G9153-Mapcp demonstration - physician incentive pool
• G9157-Transesophageal doppler use for cardiac monitoring
• G9158-Motor speech functional limitation, discharge status at discharge from therapy/end of reporting on limitation
• G9159-Spoken language comprehension functional limitation, current status at time of initial therapy treatment/episode outset and reporting intervals
• G9160-Spoken language comprehension functional limitation, projected goal status at initial therapy treatment/outset and at discharge from therapy
• G9161-Spoken language comprehension functional limitation, discharge status at discharge from therapy/end of reporting on limitation
• G9162-Spoken language expression functional limitation, current status at time of initial therapy treatment/episode outset and reporting intervals
• G9163-Spoken language expression functional limitation, projected goal status at initial therapy treatment/outset and at discharge from therapy
• G9164-Spoken language expression functional limitation, discharge status at discharge from therapy/end of reporting on limitation
• G9165-Attention functional limitation, current status at time of initial therapy treatment/episode outset and reporting intervals
• G9166-Attention functional limitation, projected goal status at initial therapy treatment/outset and at discharge from therapy
• G9167-Attention functional limitation, discharge status at discharge from therapy/end of reporting on limitation
• G9168-Memory functional limitation, current status at time of initial therapy treatment/episode outset and reporting intervals
• G9169-Memory functional limitation, projected goal status at initial therapy treatment/outset and at discharge from therapy
• G9170-Memory functional limitation, discharge status at discharge from therapy/end of reporting on limitation
• G9171-Voice functional limitation, current status at time of initial therapy treatment/episode outset and reporting intervals
• G9172-Voice functional limitation, projected goal status at initial therapy treatment/outset and at discharge from therapy
• G9173-Voice functional limitation, discharge status at discharge from therapy/end of reporting on limitation
• G9174-Other speech language pathology functional limitation, current status at time of initial therapy treatment/episode outset and reporting intervals
• G9175-Other speech language pathology functional limitation, projected goal status at initial therapy treatment/outset and at discharge from therapy
• G9176-Other speech language pathology functional limitation, discharge status at discharge from therapy/end of reporting on limitation
• G9186-Motor speech functional limitation, projected goal status at initial therapy treatment/outset and at discharge from therapy
• J0178-Injection, aflibercept, 1 mg
• J0485-Injection, belatacept, 1 mg
• J0716-Injection, centruroides immune f(ab)2, up to 120 milligrams
• J0890-Injection, peginesatide, 0. 1 mg (for esrd on dialysis)
• J1050-Injection, medroxyprogesterone acetate, 1 mg
• J1741-Injection, ibuprofen, 100 mg
• J1744-Injection, icatibant, 1 mg
• J2212-Injection, methylnaltrexone, 0. 1 mg
• J7178-Injection, human fibrinogen concentrate, 1 mg
• J7315-Mitomycin, opthalmic, 0. 2 mg
• J7527-Everolimus, oral, 0. 25 mg
• J9002-Injection, doxorubicin hydrochloride, liposomal, doxil, 10 mg
• J9019-Injection, asparaginase (erwinaze), 1,000 iu
• J9042-Injection, brentuximab vedotin, 1 mg
• Q2034-Influenza virus vaccine, split virus, for intramuscular use (agriflu)
• Q2049-Injection, doxorubicin hydrochloride, liposomal, imported lipodox, 10 mg
• Q4131-Epifix, per square centimeter
• Q4132-Grafix core, per square centimeter
• Q4133-Grafix prime, per square centimeter
• Q4134-Hmatrix, per square centimeter
• Q4135-Mediskin, per square centimeter
• Q4136-Ez-derm, per square centimeter
• Q9969-Tc-99m from non-highly enriched uranium source, full cost recovery add-on, per study dose
• V5281-Assistive listening device, personal fm/dm system, monaural, (1 receiver, transmitter, microphone), any type
• V5282-Assistive listening device, personal fm/dm system, binaural, (2 receivers, transmitter, microphone), any type
• V5283-Assistive listening device, personal fm/dm neck, loop induction receiver
• V5284-Assistive listening device, personal fm/dm, ear level receiver
• V5285-Assistive listening device, personal fm/dm, direct audio input receiver
• V5286-Assistive listening device, personal blue tooth fm/dm receiver
• V5287-Assistive listening device, personal fm/dm receiver, not otherwise specified
• V5288-Assistive listening device, personal fm/dm transmitter assistive listening device
• V5289-Assistive listening device, personal fm/dm adapter/boot coupling device for receiver, any type
• V5290-Assistive listening device, transmitter microphone, any type

Deleted HCPCS

HCPCS and Description

• D0360-Cone beam ct - craniofacial data capture
• D0362-Cone beam - two-dimensional image reconstruction using existing data, includes multiple images
• D1203-Topical application of fluoride - child
• D1204-Topical application of fluoride - adult
• D4271-Free soft tissue graft procedure (including donor site surgery)
• D6254-Interim pontic
• D6795-Interim retainer crown
• D6970-Post and core in addition to fixed partial denture retainer, indirectly fabricated
• D6972-Prefabricated post and core in addition to bridge retainer
• D6973-Core build up for retainer, including any pins
• D6976-Each additional indirectly fabricated post - same tooth
• D6977-Each additional prefabricated post - same tooth
• G0290-Transcatheter placement of a drug eluting intracoronary stent(s), percutaneous, with or without other therapeutic intervention, any method; single vessel
• G0291-Transcatheter placement of a drug eluting intracoronary stent(s), percutaneous, with or without other therapeutic intervention, any method; each additional vessel
• G0911-Assessed level of activity and symptoms
• G0912-Level of activity and symptoms not assessed
• G8447-Patient encounter was documented using an ehr system that has been certified by an authorized testing and certification body (atcb)
• G8448-Patient encounter was documented using a pqri qualified ehr or other acceptable systems
• G8468-Angiotensin converting enzyme (ace) inhibitor or angiotensin receptor blocker (arb) therapy prescribed for patients with a left ventricular ejection fraction (lvef) <40% or documentation of moderately or severely depressed left ventricular systolic function
• G8469-Clinician documented that patient with a left ventricular ejection fraction (lvef) <40% or documentation of moderately or severely depressed left ventricular systolic function was not an eligible candidate for angiotensin converting enzyme (ace) inhibitor or angiotensin receptor blocker (arb) therapy
• G8470-Patient with left ventricular ejection fraction (lvef) >=40% or documentation as normal or mildly depressed left ventricular systolic function
• G8471-Left ventricular ejection fraction (lvef) was not performed or documented
• G8472-Angiotensin converting enzyme (ace) inhibitor or angiotensin receptor blocker (arb) therapy not prescribed for patients with a left ventricular ejection fraction (lvef) <40% or documentation of moderately or severely depressed left ventricular systolic function, reason not specified
• G8524-Patch closure used for patient undergoing conventional cea
• G8525-Clinician documented that patient did not receive conventional cea
• G8526-Patch closure not used for patient undergoing conventional cea, reason not specified
• G8546-I intend to report the community-acquired pneumonia (cap) measures group
• G8550-All quality actions for the applicable measures in the community-acquired pneumonia (cap) measures group have been performed for this patient
• G8675-Most recent systolic blood pressure >= 140 mm hg
• G8676-Most recent diastolic blood pressure >= 90 mm hg
• G8677-Most recent systolic blood pressure < 130 mm hg
• G8678-Most recent systolic blood pressure 130 to 139 mm hg
• G8679-Most recent diastolic blood pressure < 80 mm hg
• G8680-Most recent diastolic blood pressure 80 - 89 mm hg
• G8695-Left ventricular ejection fraction (lvef) >= 40% or documentation as mildly depressed left ventricular systolic function or normal
• G8715-Hemodialysis treatment performed less than three times per week or greater than three times per week
• G8716-Documentation of reason(s) for patient not having greater than or equal to 1. 2 (single-pool clearance of urea [kt] / volume [v])
• G8727-Patient receiving hemodialysis, peritoneal dialysis or kidney transplantation
• G8750-Presence of signs of melanoma (cough, dyspnea, tenderness, localized neurologic signs such as weakness, jaundice or any other sign suggesting systemic spread) or presence of symptoms of melanoma (pain, paresthesia, or any other symptom suggesting the possibility of systemic spread of melanoma)
• G8760-All quality actions for the applicable measures in the epilepsy measures group have been performed for this patient
• G8786-Severity of angina assessed according to level of activity
• G8787-Angina assessed as present
• G8788-Angina assessed as absent
• G8789-Severity of angina not assessed according to level of activity
• G8802-Pregnancy test (urine or serum) ordered
• G8803-Pregnancy test (urine or serum) not ordered for reasons documented by clinician
• G8805-Pregnancy test (urine or serum) was not ordered, reason not specified
• G8819-Aneurysm minor diameter <= 5. 5 cm
• G8820-Aneurysm minor diameter 5. 6-6. 0 cm
• G8821-Abdominal aortic aneurysm is not infarenal
• G8822-Male patients with aneurysms minor diameter >6 cm
• G8823-Female patients with aneurysm minor diameter >6cm
• G8824-Female patients with aneurysm minor diameter 5. 6-6. 0 cm
• G8828-Aneurysm minor diameter <= 5. 5 cm for men
• G8829-Aneurysm minor diameter 5. 6-6. 0 cm for men
• G8830-Aneurysm minor diameter >6cm for men
• G8831-Aneurysm minor diameter >6cm for women
• G8832-Aneurysm minor diameter 5. 6-6. 0 cm for women
• G8836-Symptomatic patient with ipsilateral stroke or tia within 120 days prior to cea
• G8837-Other symptomatic patient with ipsilateral carotid territory tia or stroke >120 days prior to cea, or contralateral carotid territory tia or stroke or vertebrobasilar tia or stroke
• G8847-Positive airway pressure therapy not prescribed
• G8901-I intend to report the epilepsy measures group
• G9141-Influenza a (h1n1) immunization administration (includes the physician counseling the patient/family)
• G9142-Influenza a (h1n1) vaccine, any route of administration
• J1051-Injection, medroxyprogesterone acetate, 50 mg
• J1055-Injection, medroxyprogesterone acetate for contraceptive use, 150 mg
• J1056-Injection, medroxyprogesterone acetate / estradiol cypionate, 5mg / 25mg
• J1680-Injection, human fibrinogen concentrate, 100 mg
• J8561-Everolimus, oral, 0. 25 mg
• J9001-Injection, doxorubicin hydrochloride, all lipid formulations, 10 mg
• Q2045-Injection, human fibrinogen concentrate, 1 mg
• Q2046-Injection, aflibercept, 1 mg
• Q2047-Injection, peginesatide, 0. 1 mg (for esrd on dialysis)
• Q2048-Injection, doxorubicin hydrochloride, liposomal, doxil, 10 mg

Deleted Modifiers

Modifier and Description

• V8-INFECTION PRESENT
• V9-NO INFECTION PRESENT